Daniel Faga is EVP, Chief Operating Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 30,638 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Feb 02, 2021, when has been sold 1,340 shares (Common Stock) at a price of $194.38 per share, resulting in proceeds of $260,469. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.6K
0% 3M change
0% 12M change
Total Value Held $0

Daniel Faga Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
SELL
Open market or private sale
$260,469 $194.38 p/Share
1,340 Reduced 4.19%
30,638 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$153,202 $114.33 p/Share
1,340 Added 4.02%
31,978 Common Stock
Jan 15 2021
BUY
Grant, award, or other acquisition
-
7,023 Added 18.65%
30,638 Common Stock
Jan 07 2021
SELL
Open market or private sale
$566,528 $215.82 p/Share
2,625 Reduced 10.0%
23,615 Common Stock

Also insider at

ANAB
ANAPTYSBIO, INC Healthcare
DF

Daniel Faga

EVP, Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX